NCT00189241View on ClinicalTrials.gov

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Basal Cell Carcinoma
Interventions
DRUG

imiquimod

Trial Locations (1)

Unknown

Univertätsklinik für Dermatologie und Venerologie, Magedeburg

All Listed Sponsors
lead

MEDA Pharma GmbH & Co. KG

INDUSTRY

NCT00189241 - A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma | Biotech Hunter | Biotech Hunter